Sun Valley Gold sells Vista Gold (VGZ) shares worth $2.16 million
Director Jack Bendheim and BFI Co., LLC, a ten percent owner, reported selling shares of PHIBRO ANIMAL HEALTH CORP (NASDAQ:PAHC) on November 4th and 5th, 2025, for a total of approximately $296,778. The insider selling comes as PAHC trades near its 52-week high of $44.35, with the stock delivering an impressive 127.92% return over the past six months.
The sales, executed under a pre-arranged Rule 10b5-1 trading plan, involved multiple transactions with prices ranging from $40.9805 to $43.6205. Specifically, on November 4th, 2,996 shares were sold at a weighted average price of $43.0061, and 524 shares were sold at a weighted average price of $43.6205. On November 5th, 2,548 shares were sold at a weighted average price of $40.9805, and 972 shares were sold at a weighted average price of $41.8278.
On November 4th, BFI Co., LLC also converted 25,000 shares of Class B Common Stock into Class A Common Stock.
Following these transactions, BFI Co., LLC indirectly holds 62,400 shares of Class A Common Stock, while Jack Bendheim directly holds 16,840 shares.
In other recent news, Phibro Animal Health Corporation reported impressive financial results for the first quarter of fiscal year 2026. The company posted earnings per share of $0.73, significantly outperforming analysts’ expectations of $0.60. Additionally, Phibro’s revenue reached $363.9 million, surpassing the anticipated $345.44 million. This earnings surprise was well-received by investors, as it highlighted the company’s strong performance. In related developments, BofA Securities raised its price target for Phibro Animal Health from $27.00 to $32.00 while maintaining an Underperform rating. The revised target reflects increased demand for protein and improved profitability in the Livestock sector, coupled with lower costs for feed and grain inputs. These factors contribute to strengthening Phibro’s position within the industry. The recent earnings results and analyst actions indicate positive momentum for the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.